Challenging Scenarios: Managing Virologic Failure in a Heavily Treatment–Experienced Patient
Listen as an expert uses a case scenario to discuss choosing a new ART regimen for a person living with HIV who is heavily treatment experienced with multidrug-resistant HIV, including guideline recommendations and data for novel-mechanism ART agents.
Decera Clinical Education Infectious Disease Podcast · Renslow Sherer MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Renslow Sherer, MD, discusses managing virologic failure in a person living with HIV who is heavily treatment experienced, including:
- Guideline recommendations for selecting a new ART regimen
- Options for patients with multidrug-resistant HIV from existing drug classes and novel mechanisms of action with no cross-resistance
- Data from TMB-301 and TMB-311 for ibalizumab, BRIGHTE for fostemsavir, and CAPELLA for lenacapavir on the use of these agents for people living with HIV who are heavily treatment experienced with multidrug-resistant HIV
Presenter:
Renslow Sherer, MD
Director
International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois
To download the slides:
https://bit.ly/3OcqxIE
To view the full online program:
https://bit.ly/3ZjSFhg
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.